Pharmaceuticals $500K+ Reviewed

Methylphenidate ER

DLA

methylphenidate tablets extended-release medication prescription pharmaceuticals $500K+

Posted Sep 23, 2026

Due Oct 23, 2026

Description

The Defense Logistics Agency plans a national requirements contract for methylphenidate ER tablets in 18 mg, 27 mg, 36 mg, and 54 mg strengths, packaged in 100-count bottles, with a one-year base and four one-year options; annual usage estimates will appear in the solicitation schedule. The acquisition is unrestricted and fully competitive, firm-fixed-price, and solicited as a commercial item under FAR Part 12, with supply for Department of War, VA, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs; the solicitation is projected for September 2026 and will be posted on DIBBS and SAM.gov.

A strong match for healthcare vendors

Curated for medical & healthcare suppliers

Why we classified this as medical

The solicitation is for Methylphenidate ER tablets in multiple strengths, a prescription pharmaceutical, and describes an unrestricted, fully competitive national supply contract for DLA, VA, IHS, and Bureau of Prisons customers. The one-year base plus four option years and national distribution indicate a large procurement.

View Original Source

Save for Later

Send to Pipeline